| Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
 | HR (95% CI) | p value | HR (95% CI) | p value |
Age | 1.02 (1.00–1.04) | 0.078 |  |  |
Gender (Male / Female) | 0.82 (0.52–1.30) | 0.40 |  |  |
BMI | 0.97 (0.92–1.02) | 0.21 |  |  |
Albumin (g/dL) | 0.70 (0.48–1.02) | 0.06 |  |  |
Total bilirubin (mg/dL) | 1.15 (0.66–2.01) | 0.64 |  |  |
PT-INR | 6.18 (1.23–31.10) | 0.027 |  |  |
Platelet count (× 104/μL) | 1.00 (0.99–1.01) | 0.46 |  |  |
AFP (ng/mL) | 1.00 (1.00–1.00) | 0.63 |  |  |
DCP (mAU/mL) | 1.00 (1.00–1.00) | 0.44 |  |  |
ICG R15 (%) | 1.04 (1.00–1.03) | 0.061 |  |  |
LHL15 | 0.019 (0.00–0.75) | 0.034 | 0.019 (0.00–0.75) | 0.034 |
PNI | 0.96 (0.93–0.99) | 0.013 |  |  |
Underlying liver disease NBNC / HBV / HCV | 0.69 (0.47–1.00) | 0.05* |  |  |
Maximum tumor diameter (cm) | 1.03 (0.98–1.08) | 0.25 |  |  |
Multiple tumor nodules | 1.41 (0.93–2.15) | 0.11 |  |  |
BCLC stage 0/A/B/C | 2.37 (1.16–4.82) | 0.018** |  |  |
Up-to-7 criteria out | 1.29 (0.88–1.89) | 0.20 |  |  |
5–5-500 criteria out | 1.01 (0.71–1.44) | 0.97 |  |  |
Anatomical resection | 0.84 (0.59–1.21) | 0.35 |  |  |
Laparoscopic | 1.23 (0.80–1.89) | 0.35 |  |  |